LINC00934

Across TCGA pan-cancer cohorts, LINC00934 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC00934’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where LINC00934 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00934 is over-expressed in tumor, although a few such as BLCA and THCA show the opposite, repressed pattern.

BLCA, THCA, and KIRP are the cancer types where LINC00934 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00934 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	III,IV	−0.019	.006	4	view →
THCA	Female	All	−0.019	.038	1	view →
KIRP	Male	All	−0.014	.026	1	view →
LUSC	Male	All	−0.007	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LINC00934–BLCA

Open the BLCA breakdown →